A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Recruiting · NCT07023289 · Registry updated 2026-10-09

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder	Recruiting	Phase 2	2026-10-09		NCT07023289

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AbbVie	340

48 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aarhus Universitetshospital - Skejby /ID# 274498	Aarhus	Denmark	1
Aichi Cancer Center /ID# 275479	Nagoya	Japan	1
Asan Medical Center /ID# 274454	Seoul	South Korea	1
Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 273540	Naples	Italy	1
Azienda Ospedaliero Universitaria Careggi /ID# 273604	Florence	Italy	1
China Medical University Hospital /ID# 274644	Taichung	Taiwan	1
CHU de Liege /ID# 278857	Liège	Belgium	1
Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621	Huntsville	United States	1
Cliniques Universitaires UCL Saint-Luc /ID# 278669	Brussels	Belgium	1
Duke University Medical Center /ID# 279457	Durham	United States	1
Gifu University Hospital /ID# 274179	Gifu	Japan	1
Hospital Universitario de Salamanca /ID# 273719	Salamanca	Spain	1
Hospital Universitario La Paz /ID# 273718	Madrid	Spain	1
Hospital Universitario Virgen del Rocio /ID# 273720	Seville	Spain	1
Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586	Fairfax	United States	1
IRCCS Istituto Clinico Humanitas /ID# 273566	Rozzano	Italy	1
Johns Hopkins Hospital /ID# 275645	Baltimore	United States	1
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 273745	Kaohsiung City	Taiwan	1
Kyushu University Hospital /ID# 273710	Fukuoka	Japan	1
Massachusetts General Hospital /ID# 273608	Boston	United States	1
Mayo Clinic Hospital Jacksonville /ID# 274472	Jacksonville	United States	1
Mayo Clinic-Rochester /ID# 273508	Rochester	United States	1
Moffitt Cancer Center /ID# 274372	Tampa	United States	1
National Cancer Center Hospital East /ID# 273614	Kashiwa-shi	Japan	1
National Hospital Organization Osaka National Hospital /ID# 274306	Osaka	Japan	1

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Clinical trials

Organizations

Research sites